Bioequivalence Study of Paclitaxel for Injection (Albumin Bound) in Subjects With Breast Cancer

NCT06765590 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: T, 260 mg/m2, paclitaxel for injection (albumin-bound)
DRUG: R, 260 mg/m2, paclitaxel for injection (albumin bound).

Sponsor

Sichuan Huiyu Pharmaceutical Co., Ltd

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]